DCM Shriram announces the liquidation of its wholly-owned step-down subsidiary, Bioseed Research USA Inc., effective December 15, 2025. The company received official notification on December 19, 2025. This action concludes all operations of the subsidiary, subject to necessary local tax and accounting filings.
Liquidation Announcement
DCM Shriram has confirmed the liquidation of Bioseed Research USA Inc., a wholly-owned step-down subsidiary. The liquidation became effective on December 15, 2025. The parent company received confirmation today, December 19, 2025, at approximately 4:00 a.m. (IST). With this liquidation, Bioseed Research USA Inc. ceases to operate as a subsidiary of DCM Shriram.
Financial Impact and Details
As of March 31, 2025, Bioseed Research USA Inc. had a turnover of Nil and a net worth of USD 3271. The liquidation process is subject to necessary tax and accounting filings in accordance with local laws. No agreements for sale were entered into as the entity was voluntarily liquidated. The company has stated that this transaction does not involve related parties and is not part of any scheme of arrangement.
Source: BSE
